Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Double-blind, Randomized, Stratified and Controlled Clinical Trial With Split-virion and Whole-virion, Adjuvanted and Non-adjuvanted Influenza A/H1N1 Vaccines in Healthy Adults, Elders, Adolescents and Children
Brief Summary: A single center, stratified, randomized and double-blind phase IV clinical trial is to be conducted in healthy elders (equal to or more than 61 years), adults (18-60 years), adolescents (12-17 years) and children (3-11 years) to evaluate the safety and immunogenicity of Sinovac's split-virion or whole-virion novel influenza A (H1N1) vaccines.


Options:
A: Arm Label: split-virion, adjuvanted H1N1 vaccine of 7.5 μg; Type: EXPERIMENTAL; Interventions: Biological: split-virion, adjuvanted H1N1 vaccine of 7.5 μg per dose | Arm Label: split-virion, adjuvanted H1N1 vaccine of 15 μg; Type: EXPERIMENTAL; Interventions: Biological: split-virion, adjuvanted H1N1 vaccine of 15 μg per dose | Arm Label: split-virion, non-adjuvanted H1N1 vaccine of 15 μg; Type: EXPERIMENTAL; Interventions: Biological: split-virion, non-adjuvanted H1N1 vaccine of 15 μg per dose | Arm Label: split-virion, non-adjuvanted H1N1 vaccine of 30 μg; Type: EXPERIMENTAL; Interventions: Biological: split-virion, non-adjuvanted H1N1 vaccine of 30 μg per dose | Arm Label: whole-virion, adjuvanted H1N1 vaccine of 5 μg; Type: EXPERIMENTAL; Interventions: Biological: whole-virion, adjuvanted H1N1 vaccine of 5 μg per dose | Arm Label: whole-virion, adjuvanted H1N1 vaccine of 10 μg; Type: EXPERIMENTAL; Interventions: Biological: whole-virion, adjuvanted H1N1 vaccine of 10 μg per dose | Arm Label: Placebo control; Type: PLACEBO_COMPARATOR; Interventions: Biological: placebo control | Intervention Type: BIOLOGICAL; Name: split-virion, adjuvanted H1N1 vaccine of 7.5 μg per dose; Assigned to Arm(s): split-virion, adjuvanted H1N1 vaccine of 7.5 μg | Intervention Type: BIOLOGICAL; Name: split-virion, adjuvanted H1N1 vaccine of 15 μg per dose; Assigned to Arm(s): split-virion, adjuvanted H1N1 vaccine of 15 μg | Intervention Type: BIOLOGICAL; Name: split-virion, non-adjuvanted H1N1 vaccine of 15 μg per dose; Assigned to Arm(s): split-virion, non-adjuvanted H1N1 vaccine of 15 μg | Intervention Type: BIOLOGICAL; Name: split-virion, non-adjuvanted H1N1 vaccine of 30 μg per dose; Assigned to Arm(s): split-virion, non-adjuvanted H1N1 vaccine of 30 μg | Intervention Type: BIOLOGICAL; Name: whole-virion, adjuvanted H1N1 vaccine of 5 μg per dose; Assigned to Arm(s): whole-virion, adjuvanted H1N1 vaccine of 5 μg | Intervention Type: BIOLOGICAL; Name: whole-virion, adjuvanted H1N1 vaccine of 10 μg per dose; Assigned to Arm(s): whole-virion, adjuvanted H1N1 vaccine of 10 μg | Intervention Type: BIOLOGICAL; Name: placebo control; Assigned to Arm(s): Placebo control
B: Arm Label: MI plus respiratory illness; Type: N/A; Interventions: N/A
C: Arm Label: Influenza A (H5N1) 18-64Y Group; Type: EXPERIMENTAL; Interventions: Biological: Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted | Arm Label: Placebo 18-64Y Group; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Arm Label: Influenza A (H5N1) >64Y Group; Type: EXPERIMENTAL; Interventions: Biological: Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted | Arm Label: Placebo >64Y Group; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Arm Label: Influenza A (H5N1) Group; Type: EXPERIMENTAL; Interventions: Biological: Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted | Arm Label: Placebo Group; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Arm Label: Influenza A (H5N1) 18-60Y Group; Type: EXPERIMENTAL; Interventions: Biological: Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted | Arm Label: Placebo 18-60Y Group; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Arm Label: Influenza A (H5N1) >60Y Group; Type: EXPERIMENTAL; Interventions: Biological: Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted | Arm Label: Placebo >60Y Group; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted; Assigned to Arm(s): Influenza A (H5N1) 18-60Y Group, Influenza A (H5N1) 18-64Y Group, Influenza A (H5N1) >60Y Group, Influenza A (H5N1) >64Y Group, Influenza A (H5N1) Group | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Placebo 18-60Y Group, Placebo 18-64Y Group, Placebo >60Y Group, Placebo >64Y Group, Placebo Group
D: Arm Label: active vaccine; Type: EXPERIMENTAL; Interventions: Biological: Influenza vaccination: Influvac (SolvayPharma) | Arm Label: placebo vaccine; Type: PLACEBO_COMPARATOR; Interventions: Biological: placebo influenza vaccine | Intervention Type: BIOLOGICAL; Name: Influenza vaccination: Influvac (SolvayPharma); Assigned to Arm(s): active vaccine | Intervention Type: BIOLOGICAL; Name: placebo influenza vaccine; Assigned to Arm(s): placebo vaccine

Answer: A